Bifrost Biolabs ApS: Financial statements 2020
CVR: 38704001
Source: annual report 2020, Danish Business Authority
01/04/2019 – 31/03/2020
Bifrost Biolabs ApS (CVR 38704001) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 343,763 and a net result of DKK -82,887 compared with DKK -5,683 the year before. That is an increase of 926.6% compared with the year before. Equity in the 2020 report amounted to DKK -29,479. The company had 1 employee in the financial year.
- Gross Profit
- DKK 343,763
- Profit/Loss
- DKK -82,887
- Equity
- DKK -29,479
- Total Assets
- DKK 81,983
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 344 t. | -83 t. | -29 t. | 1 |
| 2019 | - | 33 t. | -6 t. | 23 t. | 1 |
Official annual report
How creditworthy is Bifrost Biolabs ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 30, 2020, Vilhelm Krarup Møller has left the board of directors of Bifrost Biolabs ApS.
As of December 30, 2020, Jesper Møller has stepped down as director of Bifrost Biolabs ApS.
As of December 30, 2020, Hasse Hedeby has stepped down as director of Bifrost Biolabs ApS.
As of November 26, 2020, Vilhelm Krarup Møller has joined the board of directors of Bifrost Biolabs ApS.
As of November 26, 2020, Lasse Blirup Snejbjerg is registered as chairman of Bifrost Biolabs ApS.
As of November 26, 2020, Lasse Blirup Snejbjerg is registered as adm. dir. of Bifrost Biolabs ApS.
As of November 26, 2020, Vilhelm Krarup Møller has stepped down as adm. dir. of Bifrost Biolabs ApS.
As of November 25, 2020, Vilhelm Krarup Møller has stepped down as chairman of Bifrost Biolabs ApS.
About Bifrost Biolabs ApS
Bifrost Biolabs ApS was a Danish company of the type Anpartsselskab based in Glostrup, founded in 2017. The company has been dissolved on 26 July 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. According to the 2021 annual report, the company had an average of 1 employee. In 2021, the company reported a gross profit of DKK -90,649 and a net result of DKK -421,997 compared with DKK -82,887 the year before. Equity in the 2021 report amounted to DKK -381,762.